Steward Partners Investment Advisory, LLC Repligen Corp Transaction History
Steward Partners Investment Advisory, LLC
- $11 Billion
- Q4 2024
A detailed history of Steward Partners Investment Advisory, LLC transactions in Repligen Corp stock. As of the latest transaction made, Steward Partners Investment Advisory, LLC holds 62 shares of RGEN stock, worth $9,345. This represents 0.0% of its overall portfolio holdings.
Number of Shares
62
Previous 93
33.33%
Holding current value
$9,345
Previous $13,000
38.46%
% of portfolio
0.0%
Previous 0.0%
Shares
17 transactions
Others Institutions Holding RGEN
# of Institutions
481Shares Held
56.3MCall Options Held
251KPut Options Held
458K-
Black Rock Inc. New York, NY7.57MShares$1.14 Billion0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD7.14MShares$1.08 Billion0.12% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.1MShares$769 Million0.01% of portfolio
-
State Street Corp Boston, MA1.69MShares$255 Million0.01% of portfolio
-
Champlain Investment Partners, LLC Burlington, VT1.54MShares$233 Million1.48% of portfolio
About REPLIGEN CORP
- Ticker RGEN
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 55,491,200
- Market Cap $8.36B
- Description
- Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....